OWC Pharmaceutical Research Takes Further Actions to Protect its Intellectual Property

This action by OWC is a key step in the Company’s continuing program to fully protect its intellectual property (“IP”). OWC’s strategy in seeking to fully protect its IP, including the filing of this European patent application will enable the Company to accelerate its ongoing discussions and negotiations regarding scientific, medical and commercial collaboration.

Commenting on the filing of the patent application, Mr. Mordechai Bignitz, Chairman and CEO of OWC Pharmaceutical Research, stated, “Our primary short-term objective is to introduce our topical cream for skin conditions including, most importantly, psoriasis to the market. Our necessity to fully protect our intellectual property limited our ability to provide potential customers and partners with the required data for their due diligence and review. Our proprietary data includes specifics regarding the formulation of the topical cream, consisting of cannabinoids and other compounds that facilitate the efficient delivery of the cream to infected areas. The filing of this

... read more at: http://www.prnewswire.com/news-releases/owc-pharmaceutical-research-takes-further-actions-to-protect-its-intellectual-property-633576713.html

Leave a Reply

Your email address will not be published. Required fields are marked *